Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-1.30
↑ 88% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthElevated
Average
-11.14
Historical baseline
PeriodValueYoY Change
2024-1.30+47.9%
2023-2.49+45.7%
2022-4.59+88.0%
2021-38.34-210.7%
2020-12.34-59.2%
2019-7.75-